SIIs

PTI New Delhi, July 12The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to Serum Institute of India (SII) to…

PTI New Delhi, June 24An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to Serum…

PTI New Delhi, May 3 Serum Institute of India's coronavirus vaccine Covovax is now available for children across the country, company CEO Adar…

Children aged 12 to 17 years can now get the Serum Institute’s coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday. A dose of Covovax will cost Rs 900 plus…

Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal,…

"For practical purposes also we have appealed to the government to bring down the gap for booster dose from nine months to six months," says Adar Poonawalla, CEO, Serum Institute of India. On third booster dose being available for Rs…

Covid working group of NTAGI will review this week data of Serum Institute of India’s (SII) anti-coronavirus jab Covovax to decide whether it can be included in the national COVID-19 vaccination programme for inoculating those aged 12 years…

PTI New Delhi, March 9India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for the…

Director, Government and Regulatory Affairs at the SII, Prakash Kumar Singh had put in an application to the DCGI on January 6 stating the Pune-based firm, in collaboration with Novavax Inc, is working on the development of a vaccine…

New Delhi, December 27   An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India’s Covid-19 vaccine…